Onychomycosis

CPD
By
AP Staff
-

References

  1. Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–51.
  2. Gupta AK, Mays RR. The impact of onychomycosis on quality of life: a systematic review of the available literature. Skin Appendage Disord. 2018;4(4):208–16.
  3. Lipner SR, Scher RK. Diabetic foot and fungal infections: etiology and management from a dermatologic perspective. J Fungi (Basel). 2024;10(9):618.
  4. Elewski BE, Tosti A. Risk factors and comorbidities for onychomycosis: implications for treatment with topical therapy. J Clin Aesthet Dermatol. 2015;8(11):38–42.
  5. Kovitwanichkanont T, Chong AH. Superficial fungal infections. Aust J Gen Pract. 2019;48(10):706–11.
  6. Bodman MA, Syed HA, Krishnamurthy K. Onychomycosis. Treasure Island (FL): StatPearls Publishing; 2026. At: https://www.ncbi.nlm.nih.gov/books/NBK441853/
  7. Onychomycosis. In: eTG complete. Melbourne: Therapeutic Guidelines Limited. 2025. At: https://www.tg.org.au
  8. DermNet NZ. Fungal nail infections. 2022. At: https://dermnetnz.org/topics/fungal-nail-infections
  9. Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. Am Fam Physician. 2013;88(11):762–70.
  10. Tosti A, Elewski BE. Onychomycosis: practical approaches to minimize relapse and recurrence. Skin Appendage Disord. 2016;2(1–2):83–7.
  11. Bristow IR, Baran R. Topical and oral combination therapy for toenail onychomycosis: an updated review. J Am Podiatr Med Assoc. 2006;96(2):116–9.
  12. Leung AKC, Lam JM, Leong KF, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32–45.
  13. Buckley N, ed. Terbinafine. 2025. At: https://amhonline.amh.net.au
  14. Meretsky CR, Friday BL, Schiuma AT. Efficacy of laser therapy in comparison with other methods for the treatment of onychomycosis: a systematic review and meta-analysis. Cureus. 2024;16(5):e59720.
  15. Lazzarini PA, Raspovic A, Prentice J, et al. Australian evidence-based guidelines for the prevention and management of diabetes-related foot disease: a guideline summary. Med J Aust. 2023;219(10):485–95.